Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.22.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance, beginning at Sep. 30, 2020 $ 2,315 $ 74,850,935 $ (43,558,602) $ 31,294,648
Balance, beginning, shares at Sep. 30, 2020 23,154,084      
Stock-based compensation expense   3,696,384   3,696,384
Issuance of restricted stock for services $ 1 (1)    
Issuance of restricted stock for services (in shares) 11,722      
Exercise of stock options $ 5 112,441   $ 112,446
Exercise of stock options (in shares) 47,052     47,052
Issuance of common stock, net of issuance costs $ 920 42,615,456   $ 42,616,376
Issuance of common stock, net of issuance costs (in shares) 9,200,000      
Issuance of common stock, Vera acquisition $ 31 1,759,189   1,759,220
Issuance of common stock, Vera acquisition (in shares) 308,635      
Net loss     (25,409,301) (25,409,301)
Balance, ending at Sep. 30, 2021 $ 3,272 123,034,404 (68,967,903) 54,069,773
Balance, ending, shares at Sep. 30, 2021 32,721,493      
Stock-based compensation expense   2,897,689   2,897,689
Issuance of restricted stock for services (in shares) 4,441      
Forfeiture of common stock $ (51) 51    
Forfeiture of common stock (in shares) (509,527)      
Exercise of stock options $ 79 789   $ 868
Exercise of stock options (in shares) 792,250     792,250
Net loss     (33,776,450) $ (33,776,450)
Balance, ending at Sep. 30, 2022 $ 3,300 $ 125,932,933 $ (102,744,353) $ 23,191,880
Balance, ending, shares at Sep. 30, 2022 33,008,657